Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Net Income of -$105.04 million for fiscal year 2025.
CAPRICOR THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$105.04M | -159.6% |
| 2024 | -$40.47M | -81.6% |
| 2023 | -$22.29M | +23.2% |
| 2022 | -$29.02M | -44.9% |
| 2021 | -$20.02M | -46.6% |
| 2020 | -$13.66M | -78.7% |
| 2019 | -$7.64M | +49.7% |
| 2018 | -$15.19M | -724.8% |
| 2017 | $2.43M | +112.9% |
| 2016 | -$18.81M | -46.3% |
| 2015 | -$12.86M | -106.8% |
| 2014 | -$6.22M | +30.1% |
| 2013 | -$8.89M | -329.3% |
| 2012 | -$2.07M | -80.2% |
| 2011 | -$1.15M | -8.9% |
| 2010 | -$1.06M | -608.7% |
| 2009 | -$149.0K | +76.4% |
| 2008 | -$630.9K | +35.6% |
| 2007 | -$979.1K | +16.4% |
| 2006 | -$1.17M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$24.57M | -95.7% | +5.2% |
| June 30, 2025 | -$25.91M | -135.6% | -6.2% |
| March 31, 2025 | -$24.39M | -149.0% | -94.3% |
| September 30, 2024 | -$12.56M | -96.5% | -14.2% |
| June 30, 2024 | -$11.00M | -49.3% | -12.3% |
| March 31, 2024 | -$9.79M | -26.1% | -53.3% |
| September 30, 2023 | -$6.39M | -0.3% | +13.2% |
| June 30, 2023 | -$7.37M | -3.6% | +5.2% |
- CAPRICOR THERAPEUTICS, INC. showed a decrease of -159.6% in Net Income compared to the prior fiscal year.
- Over the 2006–2025 period, CAPRICOR THERAPEUTICS, INC.’s net income has declined by 8867.2% (from -$1.17 million to -$105.04 million).
- The most recent figure is from CAPRICOR THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: